SCHEMBL2807452

SCHEMBL2807452

COCCCn1nc(CO)c2cc(F)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 5/20 0.38
KDM4E B2RXH2 3/20 0.37
HSD17B10 Q99714 2/20 0.37
SSTR5 P35346 1/20 0.37
REN P00797 3/20 0.36
PER2 O15055 2/20 0.35
CRY1 Q16526 2/20 0.35
CRY2 Q49AN0 2/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 2/20 0.33
ELANE P08246 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131355 0.90 KDM4C (0.38) KDM4CKDM4EHSD17B10SSTR5REN
SCHEMBL2808571 0.84 MAPK8 (0.46) KDM4CKDM4EHSD17B10RENALDH1A1
SCHEMBL19597374 0.84 ADORA2A (0.42) KDM4CKDM4EHSD17B10RENPER2
SCHEMBL15791921 0.83 KDM4E (0.38) KDM4CKDM4EHSD17B10PER2CRY1
SCHEMBL2808630 0.81 OPRL1 (0.38) KDM4CREN
SCHEMBL2807490 0.81 REN (0.49) KDM4CKDM4EHSD17B10RENALDH1A1
SCHEMBL2807573 0.80 KDM4E (0.41) KDM4CKDM4EHSD17B10PER2CRY1
SCHEMBL2806451 0.78 ELANE (0.45) KDM4CKDM4EHSD17B10L3MBTL1TP53
SCHEMBL18723311 0.74 KDM4E (0.44) KDM4EHSD17B10ALDH1A1
SCHEMBL13131354 0.74 MAPK8 (0.43) KDM4CMAPK8MAPK9MAPK10CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168952-B1 MORPHOLINE DERIVATIVES AS RENIN INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2017-02-15 EP disclosed
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 US disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 US disclosed
EP-2168952-A1 MORPHOLINE DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240644-A1 MORPHOLINE DERIVATIVE REN, AGTR1, AGTR2 KDM4C 552/4885KDM4E 689/4885HSD17B10 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.